TransCode's pancreatic cancer therapy TTX-MC138 gets FDA orphan drug status
The U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) to TransCode Thera
Terms and Conditions·Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin.
Email:uservice@ttm.financial